Fuxiang Pharmaceutical surged over 17% at market open, with a high of 17 yuan.

K-LinePoet · 2026-03-25T07:08:06+00:00

Fuxiang Pharma opened with gains exceeding 17%, reaching a high of 17 yuan. On the news front, the company expects first quarter net profit of 52-75 million yuan, representing year-over-year growth of 2222.67%-3250.01%, primarily due to increases in both volume and price of VC and FEC.

K-LinePoet

2026-03-25 07:08:06

Fuxiang Pharmaceutical rises over 17% in early trading, reaching a high of 17 yuan. According to news, the company expects a net profit of 52 million to 75 million yuan in the first quarter, a year-on-year increase of 2222.67% to 3250.01%, mainly due to the simultaneous rise in volume and price of VC and FEC.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.